Depression

Desynchronized brain activity may be the key to Psilocybin-assisted treatment of Depression

In 1957, TIME magazine shocked readers with the cover story “Seeing the Magic Mushroom,” introducing most Americans, for the first time, to psychedelics [1]. The Controlled Substances Act, denoting psilocybin a Schedule 1 drug, halted the first wave of western psychedelic research in 1970,

Issue 29

Clinician Burnout: Effects on the Brain and the Healthcare Industry

Dr. Tammie Chang has just gotten off a busy day of work as a pediatric oncologist. As she drives on the road that leads to home, she feels her exhaustion

Issue 29

Beyond the Pill: Utility of Transcranial Magnetic Stimulation for Treatment-Resistant Depression

Imagine a world where depression's relentless grip is broken, where hope can finally shine through the clouds of despair. That was, unfortunately, not something Ms. T could afford to imagine.

Issue 28

Special K: The Emergence of Psychedelic Healthcare

Ketamine, a dissociative anesthetic, is notorious for its street reputation as an abused substance. Known by the general public as an illicit club drug, recreational users inhale, ingest, or inject

Issue 28

Antidepressants: The magic pill?

Disclaimer: This is a comprehensive overview of the public’s understanding on the chemical theories of depression, the marketing of antidepressants, and the importance of transparency in the pharmacotherapy and

issue 24

Tachyphylaxis: Antidepressants' Greatest Challenge

Imagine sitting down with a doctor to discuss several distressing symptoms you’ve been experiencing recently. Slowly you confess that you’ve been experiencing a sense of numbness, and your hobbies don’t interest you. In fact, nothing interests you anymore...

Issue 20

Just Dance, It'll be Okay

It starts with the hand lift – the body moves with the melody while the mind thinks about a feeling that has yet to be worked and the lungs breathe as they travel through space. Calmness, happiness, release.

Issue 18

Locating Loneliness

A lone person stands amid a bustling crowd of familiar faces. A glance around at the wide, inviting smiles on the faces of their family and friends should spark the

Issue 15

Medical Mushrooms: Psylocibin-Assisted Therapy

Psychedelics face an overwhelming stigma in Western culture that has limited scientific investigation into their uses since the 1960s. This came as a result of a lack of knowledge that

Issue 14

Up and Running

While not everyone participates in endurance sports, anyone can reap the benefits of exercise. A variety of studies show that participation in both aerobic and non-aerobic exercise for as little

Issue 11

Ketamine: A Novel Treatment For Major Depression

Finding New Ways of Thinking About Depression Within the last decade, a new agent has appeared in the spotlight of psychiatric research: ketamine. This drug, also known as “Calypsol,” is

Issue 10

Every day, millions of students experience the feeling of almost indescribable emptiness caused by major depression, also known as major depressive disorder or simply depression...

Issue 4

Bacteria and the Brain

Microbiome research is taking neurobiology to an unexpected place: the gut. Recent research has demonstrated a link between the microorganisms that live in the stomach and seemingly unrelated conditions like

The Undergraduate Neuroscience Journal

Depression

A collection of 13 posts

Desynchronized brain activity may be the key to Psilocybin-assisted treatment of Depression

Clinician Burnout: Effects on the Brain and the Healthcare Industry

Beyond the Pill: Utility of Transcranial Magnetic Stimulation for Treatment-Resistant Depression

Special K: The Emergence of Psychedelic Healthcare

Antidepressants: The magic pill?

Tachyphylaxis: Antidepressants' Greatest Challenge

Just Dance, It'll be Okay

Medical Mushrooms: Psylocibin-Assisted Therapy

Up and Running

Ketamine: A Novel Treatment For Major Depression

Depression

Bacteria and the Brain